Close
FINDING CURES TOGETHER<sup>SM</sup>

SU2C - MRA Joint Scientific Advisory Committee

Phillip A. Sharp, PhD

Chairperson
Phillip A. Sharp, PhD
Chairperson
David H. Koch Institute for Integrative Cancer Research; Massachusetts Institute of Technology
Cambridge, MA

William G. Kaelin Jr., MD

Vice-Chairperson
William G. Kaelin Jr., MD
Professor
Dana-Farber Cancer Institute
Boston, MA

Suzanne L. Topalian, MD

Vice-Chairperson
Suzanne L. Topalian, MD
Professor of Surgery and Oncology; Director
Johns Hopkins University School of Medicine; Melanoma Program, Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD

James P. Allison, PhD

James P. Allison, PhD
Chair, Department of Immunology
​University of Texas MD Anderson Cancer Center
Houston, TX

Richard B. Gaynor, MD

Richard B. Gaynor, MD
Vice President, Cancer Research and Clinical Investigation
​Eli Lilly and Company
Indianapolis, IN

Jeffrey E. Gershenwald, MD, FACS

Jeffrey E. Gershenwald, MD, FACS
Professor of Surgery and Cancer Biology
​University of Texas MD Anderson Cancer Center
Houston, TX

Thomas J. Hornyak, MD, PhD

Thomas J. Hornyak, MD, PhD
Chief, Dermatology
​University of Maryland School of Medicine
Baltimore, MD

Beverly A. Teicher, PhD

Beverly A. Teicher, PhD
Chief, Molecular Pharmacology Branch
National Cancer Institute​
Rockville, MD

Michael J. Weber, PhD

Michael J. Weber, PhD
Director
​​University of Virginia Cancer Center
Charlottesville, VA

Ellen V. Sigal, PhD

Ellen V. Sigal, PhD
Chairperson and Founder
Friends of Cancer Research​
Washington, DC

Doug Ulman

Doug Ulman
President and CEO
LIVESTRONG
Austin, TX